Joan Calzada Hernández
Investigador pre-doc
Research group
Last Publications
- Clemente D, Cuadros EN, Lovillo MC, Calzada-Hernández J, Martín SG, Silveira LF, Cruz MJL, Tagarro A, Rueda RMA, López López A, Aritziturri MS and Calvo C Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections. EUROPEAN JOURNAL OF PEDIATRICS . 183(2): 915-927.
- Anton-Lopez J, Moreno Ruzafa E, Lopez Corbeto M, Bou-Torrent R, Sánchez-Manubens J, Carriqui S, Calzada-Hernández J, Bittermann V, Estepa Guillén C, Mosquera-Angarita JM, Rodriguez-Diez L, Iglesias-Jimenez E, Marti Masanet M, Lopez Montesinos B, González Fernández MI, de Lossada A, Peral C, Valderrama M, Llevat N, Montoro Álvarez M and Calvo Penadés I Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain. Journal of Health Economics and Outcomes Research . 10(2): 141-149.
- Berrueco R, González E, Deyà-Martinez A, Solsona M, García-García AP, Calzada-Hernández J, Luo Y, Vlagea A, Ruiz-Llobet A and Alsina L Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity Frontiers in pediatrics . 11: 1174671-1174671.
Projects
- Project name:
- Desarrollo de un modelo predictivo de respuesta a tratamiento con inmunoglobulinas intravenosas en pacientes con enfermedad de Kawasaki mediante tecnología AutoDiscovery para análisis de datos en población no japonesa.
- Leader
- Joan Calzada Hernández
- Funding entities:
- Sociedad Española de Reumatología Pediátrica (SERPE)
- Code
- PCP00338
- Starting - finishing date:
- 2022 - 2024
- Project name:
- Producing an Arthritis Value-Framework with Economic Evidence
- Leader
- Jordi Antón López
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- AC21_2/00034
- Starting - finishing date:
- 2022 - 2024
- Project name:
- Caracterización de las alteraciones inmunológicas, específicamente en células Treg, implicadas en la desregulación inmune en pacientes pediátricos con errores innatos de inmunidad,hacia terapias dirigidas
- Leader
- Laia Alsina Manrique de Lara
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI21/00211
- Starting - finishing date:
- 2022 - 2024
News
-
Mutation in DOCK11 gene explains rare disorder in immune system regulation
Researchers from the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital participate in an international study, published in the prestigious scientific journal New England Journal of Medicine, which describes for the first time a new disease of the immune system caused by a mutation of the DOCK11 gene.